DNA aptamer S11e recognizes fibrosarcoma and acts as a tumor suppressor

Identification and Application of an Aptamer Targeting Papillary Thyroid Carcinoma Using Tissue-SELEX

(2019) Wen Zhong et al.   ANALYTICAL CHEMISTRY

Molecular Self-Assembly of Bioorthogonal Aptamer-Prodrug Conjugate Micelles for Hydrogen Peroxide and pH-Independent Cancer Chemodynamic Therapy

(2019) Wenjing Xuan et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells

(2018) Laia Civit et al.   BIOCHIMIE

Aptamer Therapeutics in Cancer: Current and Future

(2018) Yoshihiro Morita et al.   Cancers

Locked Nucleic Acid and Aptamers

(2018) Kasper K. Karlsen et al.   Nucleic Acid Therapeutics

Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

(2018) Hui Zhang et al.   Molecular Therapy-Nucleic Acids

Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer

(2018) Romualdo Troisi et al.   NUCLEIC ACIDS RESEARCH

Current diagnostics and treatment of fibrosarcoma –perspectives for future therapeutic targets and strategies

(2017) Daniela Augsburger et al.   Oncotarget

Rapid and Label-Free Strategy to Isolate Aptamers for Metal Ions

(2016) Hao Qu et al.   ACS Nano

A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration

(2016) Glenn J. Jaffe et al.   OPHTHALMOLOGY

Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation

(2015) Yeh-Hsing Lao et al.   ACS Nano

Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy

(2015) Xu Wu et al.   Theranostics

Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines

(2014) Ogunc Meral et al.   TUMOR BIOLOGY

The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys

(2013) F. Schwoebel et al.   BLOOD

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

(2013) J. Hoellenriegel et al.   BLOOD

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

(2013) Jonathan E. Rosenberg et al.   INVESTIGATIONAL NEW DRUGS

Update on current and future novel therapies for dry age-related macular degeneration

(2013) Ella Leung et al.   Expert Review of Clinical Pharmacology

Betanodavirus up-regulates chaperone GRP78 via ER stress: roles of GRP78 in viral replication and host mitochondria-mediated cell death

(2010) Yu-Chin Su et al.   APOPTOSIS

Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo

(2010) Varda Shoshan-Barmatz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Nucleolin on the Cell Surface as a New Molecular Target for Gastric Cancer Treatment

(2010) Tatsuro Watanabe et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Targeting mitochondria for cancer therapy

(2010) Simone Fulda et al.   NATURE REVIEWS DRUG DISCOVERY

A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease

(2010) Petra Paulinska et al.   THROMBOSIS AND HAEMOSTASIS

Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells

(2009) Zilong Zhao et al.   ANALYST

The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells

(2008) S. Soundararajan et al.   CANCER RESEARCH